SEARCH

SEARCH BY CITATION

References

  • 1
    Jacobsen L, Dreborg S, Moller C, et al. Immunotherapy as preventive treatment. J Allergy Clin Immunol 1996;97:232
  • 2
    Des Roches A, Paradis A, Menardo JL, Bouges R, Daures JP, Bousquet J. Immunotherapy with a standardized Dermatophagoides extract. Specific immunotherapy prevents the onset of new sensitizations in children. J Allergy Clin Immunol 1997;99:450 453
  • 3
    WHO Position paper. Allergen immunotherapy: therapeutic vaccines for allergic diseases. Bousquet J, Lockey RF, Malling H-J, editors. Allergy 1998;53 Suppl 44
  • 4
    Malling H-J, Abreu-Nogueira J, Alvarez-Cuesta E, et al. EAACI/ESPACI Position paper on local immunotherapy. Allergy 1998;53:833 844
  • 5
    Tari MG, Mancino M, Monti G. Efficacy of sublingual immunotherapy in patients with rhinitis and asthma due to house dust mite. A double blind study. Allergol Immunopathol (Madr) 1990;18:277 284
  • 6
    Feliziani V, Lattuada G, Parmiani S, Dall'Aglio PP. Safety and efficacy of sublingual rush immunotherapy with grass allergen extracts. A double blind study. Allergol Immunopathol (Madr) 1995;23:173 178
  • 7
    Sabbah A, Hassoun S, Le Sellin J, André C, Sicard H. A double blind placebo controlled trial by the sublingual route of immunotherapy with a standardized grass pollen extract. Allergy 1994;49:309 313
  • 8
    Troise C, Voltolini S, Canessa A, Pecora S, Negrini AC. Sublingual immunotherapy in Parietaria pollen induced rhinitis: a double blind study. J Investig Allergol Clin Immunol 1995;5:25 30
  • 9
    Passalacqua G, Albano M, Fregonese L, et al. Randomised controlled trial of local allergoid immunotherapy on allergic inflammation in mite-induced rhinoconjunctivitis. Lancet 1998;351:629 632
  • 10
    Clavel R, Bousquet J, André C. Clinical efficacy of sublingual-swallow immunotherapy. A double-blind, placebo-controlled trial of a standardized five-grass-pollen extract in rhinitis. Allergy 1998;53:493 498
  • 11
    Horak F, Stubner UE, Berger U, Marks B, Toth J, Jäger S. Immunotherapy with sublingual birch pollen extract: a short term double blind study. J Investig Allergol Clin Immunol 1998;8:165 171
  • 12
    Gozalo F, Martin S, Rico P, Alvarez E, Cortes C. Clinical efficacy and tolerance of two years' Lolium perenne sublingual immunotherapy. Allergol Immunopathol (Madr) 1997;25:219 227
  • 13
    Purello d'Ambrosio F, Ricciardi L, Isola S, et al. Rush sublingual immunotherapy in Parietaria allergic patients. Allergol Immunopathol (Madr) 1996;21:146 151
  • 14
    Quirino T, Iemoli E, Siciliani E, Parmiani S, Milazzo F. Sublingual versus injective immunotherapy in grass pollen allergic patients. A double blind double dummy study. Clin Exp Allergy 1996;26:1253 1261
  • 15
    Vourdas D, Syrigou E, Potamianou B, et al. Double-blind, placebo-controlled evaluation of sublingual immunotherapy with standardized olive pollen extract in pediatric patients with allergic rhinoconjunctivitis and mild asthma due to olive pollen sensitization. Allergy 1998;53:662 672
  • 16
    Hirsch T, Shan M, Leupold W. Double blind placebo controlled study of sublingual immunotherapy with house dust mite extract (D pt) in children. Pediatr Allergy Immunol 1997;8:21 27
  • 17
    Carreira J, Rubio M, Herrero T, et al. Collaborative clinical assay of the biological potency of allergen skin test extracts. Clin Allergy 1984;14:503 507
  • 18
    Carreira J, Lombardero M, Ventas P. New developments in in vitro methods. Quantification of clinically relevant allergens in mass units. Arbeiten aus dem Paul Ehrlich Institut. Stuttgart: Gustav Fischer Verlag, 1994
  • 19
    Almagro E, Asensio O, Bartolomé JM, et al. Estudio multicentrico de farmacovigilancia de inmunoterapia sublingual en pacientes alergicos. Allergol Immunopathol (Madr) 1995;23:153 159
  • 20
    Bernardis P, Agnoletto M, Puccinelli P, Parmiani S, Pozzan M. Injective versus sublingual immunotherapy in Alternaria tenuis allergic patients. J Investig Allergol Clin Immunol 1996;6:55 62